Concentrated Insulins: Clinical Applications and Use in Practice Settings

AACE has determined that endocrinologists, diabetologists, and other health care professionals providing care to patients receiving insulin therapy would be well-served by an educational program that improves participants’ understanding of:

  • Pharmacokinetics and pharmacodynamics of available concentrated insulins
  • Clinical results with concentrated insulin preparations, including potential benefits and risks associated with concentrated insulin use
  • Available clinical guidelines for concentrated insulin use
  • Strategies to convert to concentrated insulin use, including approaches to reduce the risk of dosing errors
  • Evidence-based approaches to successful patient education

Method of Physician Participation/How to Obtain CME Credit

  • It is anticipated that this activity will take 1.75 hours to complete.
  • Read the educational material.
  • Complete the posttest questions and get a passing mark of 70% or higher.
  • Complete the CME Activity Evaluation form.
  • Fax/mail/email the completed posttest and evaluation form for processing to:

AACE Educational Services

245 Riverside Ave., Suite 200

Jacksonville, FL. 32202

E-mail: aesstaff@aace.com

FAX: 904-404-4193

  • Only those who get a score of 70% or higher will receive credit.
  • Allow 4-6 weeks for processing of CME certificates.

Target Audience

This activity has been designed to meet the educational needs of physicians  and other healthcare professionals caring for patients with diabetes mellitus managed with insulin (eg: PA’s, NP’s, RN’s and pharmacists).

Learning Objectives

  1. Understand the increased the burden of high doses of insulin on patients.
  2. Review the epidemiology of insulin use in the US.
  3. Review clinical guidelines for insulin initiation and intensification.
  4. Compare concentrated long-acting basal insulin preparations with NPH, detemir, and U-100 glargine.
  5. Review clinical evidence with concentrated long-acting basal insulin preparations, and understand the potential for decreased risk of hypoglycemia.
  6. Discuss the potential benefits and risks associated with concentrated insulin use.
  7. Compare concentrated long-acting basal insulin preparations with NPH, detemir, and U-100 glargine.
  8. Discuss future directions in the development of concentrated insulin preparations.
  9. Discuss the role of U-500 in patients with extreme insulin resistance and challenges encountered in the clinical setting
  10. Review the similarities and differences between U-500 and U-100 regular insulin
Additional information
Available for MOC Points?: 
No
Course summary
Available credit: 
  • 1.75 AMA
  • 1.75 Attendance
Course opens: 
01/22/2017
Course expires: 
01/22/2018
Cost:
$0.00

Zachary Bloomgarden, MD; Yehuda Handelsman, MD; Lawrence Blonde, MD; Guillermo Umpierrez, MD

Available Credit

  • 1.75 AMA
  • 1.75 Attendance

Accreditation Period

Course opens: 
01/22/2017
Course expires: 
01/22/2018

Price

Cost:
$0.00
Please login or register to take this course.